Stay updated on MPS IIIB Enzyme Replacement Clinical Trial
Sign up to get notified when there's something new on the MPS IIIB Enzyme Replacement Clinical Trial page.

Latest updates to the MPS IIIB Enzyme Replacement Clinical Trial page
- Check6 days agoChange DetectedThe record describes a completed Phase 1/2 study of AX 250 for mucopolysaccharidosis type IIIB, including its safety and efficacy objectives, eligibility criteria, study locations, and outcome measures.SummaryDifference44%

- Check13 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision label advances from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the previous study content, with a minimal header and footer consistent with an error screen.SummaryDifference17%

- Check76 days agoChange DetectedThe page shows a new revision number (v3.6.6) replacing the previous v3.6.5, indicating a small maintenance update to the page metadata.SummaryDifference0.1%

Stay in the know with updates to MPS IIIB Enzyme Replacement Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MPS IIIB Enzyme Replacement Clinical Trial page.